The Rutgers Cancer Institute of New Jersey Liver Cancer and Bile Duct Cancer Program, also called the Hepatobiliary Oncology Program, is the state's only multidisciplinary healthcare group focused on liver and bile duct tumors. As the largest referral center in Central and Southern New Jersey for these cancers, the group treats patients with a wide range of liver and bile duct problems including primary liver cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (bile duct cancer) as well as metastatic liver cancers such as colorectal, gastric/esophageal, pancreatic, neuroendocrine, renal cell, breast and lung cancer. Our physicians also manage and treat a number of benign liver and bile duct issues that range from benign tumors and masses, to liver cysts and bile duct congenital abnormalities or traumatic injuries.
The Program's team of specialists provides each patient with a comprehensive evaluation by surgical oncologists, medical oncologists, radiation oncologists, interventional radiologists, gastroenterologists, pathologists, nurses, pharmacists, dietitians, and social workers. Program team members meet regularly to discuss and recommend the best treatment options for patients which may include participation in a clinical trial, many of which are only available at NCI-designated Comprehensive Cancer Centers like Rutgers Cancer Institute of New Jersey.
Our physicians see patients here in New Brunswick as well as at several RWJBarnabas Health facilities including Monmouth Medical Center, Cooperman Barnabas Medical Center, and Jersey City Medical Center.
With translational research established as an important part of the cancer center's mission, basic scientists regularly contribute their expertise assisting physicians with solving clinical problems. This integrated approach between clinicians and basic scientists allows the group to bring promising treatment options to the clinical setting at a rapid pace.
Treatment Options
- Phase I/Developmental Therapeutics Program
- Department of Radiation Oncology
- Liver Directed Therapies
- Selective Internal Radiation Therapy
Surgical Oncologists
H. Richard Alexander, Jr. MD, Chief Surgical Officer and Chief, Surgical Oncology 
Russell C. Langan, MD, Chief of Surgical Oncology & Hepatopancreatobiliary Surgery, Cooperman Barnabas Medical Center
Miral Sadaria Grandhi, MD, Director of Hepatobiliary Surgery
Timothy Kennedy, MD, MBA
Medical Oncologist
Howard Hochster, MD, FACP, Director, GI Oncology and Associate Director for Clinical Research, Rutgers Cancer Institute and Director of Oncology Research, RWJBarnabas Health
Radiologists and Radiation Oncologists
Gastroenterologists
Advanced Practice Providers
Nurses and Support Services
